Feature | Information Technology | September 22, 2015

Multidiscplinary innovations expected to drive growth in the healthcare industry

Frost & Sullivan, top medical technologies, growth, healthcare

September 22, 2015 — Frost & Sullivan released its list of top medical technologies for 2015, featuring an array of sophisticated inventions in medical devices, diagnostics and imaging. These innovations have given birth to less expensive and flexible healthcare solutions; playing a critical role in managing the increasing frequency of chronic diseases around the globe.

Analysis reveals growth in the healthcare industry will center around the following 10 technologies:

  • Surgical robots;
  • Digital pathology;
  • Neuroprosthetics;
  • Surgical lasers;
  • Smart pills;
  • Optical imaging;
  • Health informatics;
  • Integrated vital signs monitoring;
  • Artificial organs; and
  • Four-dimensional (4-D) ultrasound imaging.

New modalities such as neuroprosthesis and hybrid imaging are moving towards commercialization. Technologies already in the early commercialization phase, including smart pills and surgical robots, will find widespread uses across applications.

“The strong merits of the top 10 medical device and imaging technologies attract the attention of large and small healthcare companies alike,” said Frost & Sullivan TechVision Senior Research Analyst Bhargav Rajan. “Traditionally, cautious tier-1 firms stake claim in these pioneering modalities directly or indirectly through funding, tie-ups and acquisitions.”

A common thread connecting the 10 solutions is their scope for convergence with non-medical platforms. Innovations in electronics, sensors, information technology and advanced manufacturing are actively powering product and technology progress in medical and imaging devices. Non-healthcare businesses such as Google and IBM invest in these technologies.

“Stringent regulatory requirements as well as a competitive intellectual property landscape prolong the time-to-market and strain returns on investment,” noted Rajan. “Collaborative and multi-cluster advancements in conjunction with non-healthcare industries will significantly reduce development times and lower barriers to market entry.”

Once commercialized, these multidisciplinary medical and imaging devices with long lifespans will consistently influence market potential, research and development, and global adoption over several years.

For more information: www.frost.com


Related Content

Feature | Digital Pathology | Kyle Hardner

As recently as a decade ago, pathology technology was expected to become more expensive, larger and more precise. Yet in ...

Time October 02, 2026
arrow
News | ASTRO

Sept. 29, 2026 — The American Society for Radiation Oncology (ASTRO) has named Siemens Healthineers the inaugural ...

Time September 29, 2026
arrow
News | Computed Tomography (CT)

Sept. 17, 2026 — Royal Philips and Southwest Mississippi Regional Medical Center (SMRMC), which serves as the hub of ...

Time September 24, 2026
arrow
News | Radiology Education

Sept. 16, 2026 — As urgent care centers and outpatient healthcare facilities expand their use of diagnostic imaging, the ...

Time September 17, 2026
arrow
News | PET Imaging

Sept. 10, 2026 — Siemens Healthineers Molecular Imaging has completed a $43.6 million construction and renovation ...

Time September 14, 2026
arrow
Feature | Artificial Intelligence | Kyle Hardner

A radiologist pulls up a chest CT scan flagged for a pulmonary nodule. One artificial intelligence (AI) tool writes its ...

Time September 09, 2026
arrow
News | Ultrasound Women's Health

Sept. 3, 2026 — Royal Philips has introduced the eV14-2v transvaginal transducer, expanding its obstetrics and ...

Time September 04, 2026
arrow
News | Radiology Business

August 18, 2026 – NewVue, a provider of cloud-native software that unifies how radiologists work while improving ...

Time August 25, 2026
arrow
News | Breast Imaging

Aug. 20, 2026 — Candelis, Inc. has announced a collaboration with GE HealthCare to support the distribution of Candelis ...

Time August 24, 2026
arrow
News | Clinical Trials

Aug.12, 2026 — Mendaera Inc. has announced results from a peer-reviewed study showing that its FDA-cleared Focalist ...

Time August 17, 2026
arrow
Subscribe Now